ICECURE MEDICAL LTD.
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for women’s health and interventional oncology. Founded in 2006 to advance the treatment of cancerous tumors, IceCure’s core technology is based on cryoablation. Its proprietary third-generation technology uses freezing temperatures (liquid nitrogen) to effectively destroy tumors safely, quickly, and painlessly, without the need for surgery. Commercially available in the U.S.A., Europe, H... ong-Kong, Thailand, Singapore and South- Central America, its flagship system, ProSense™, uses ultrasound imaging to guide a small probe (thin hollow needle) into the tumor. The easy-to-use ProSense™ cryoablation procedure enables full physician control and can be performed in less than 30 minutes in the comfort of a doctor’s office. As a proven solution for the treatment of fibroadenomas (benign breast tumors), the ProSense system is also indicated for use in the fields of general surgery, oncology, gynecology and urology.
ICECURE MEDICAL LTD.
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2006-01-01
Address:
Caesarea, Hefa, Israel
Country:
Israel
Website Url:
http://www.icecure-medical.com
Total Employee:
11+
Status:
Active
Contact:
97246230222
Total Funding:
48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Clover Wolf and Clover Alpha
Clover Wolf and Clover Alpha investment in Post-IPO Equity - IceCure Medical Ltd.
Alpha Capital Anstalt
Alpha Capital Anstalt investment in Post-IPO Equity - IceCure Medical Ltd.
Rosario Capital LTD
Rosario Capital LTD investment in Post-IPO Equity - IceCure Medical Ltd.
Gal Cohen
Gal Cohen investment in Post-IPO Equity - IceCure Medical Ltd.
Yaron Iluz
Yaron Iluz investment in Post-IPO Equity - IceCure Medical Ltd.
Reut Alfia
Reut Alfia investment in Post-IPO Equity - IceCure Medical Ltd.
Naor al-Hai
Naor al-Hai investment in Post-IPO Equity - IceCure Medical Ltd.
Epoch Investment Partners
Epoch Investment Partners investment in Post-IPO Equity - IceCure Medical Ltd.
Giza Venture Capital
Giza Venture Capital investment in Series B - IceCure Medical Ltd.
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-29 | IceCure Medical Announces Appointment of Merav Nir Dotan to Vice President Human Resources |
Official Site Inspections
http://www.icecure-medical.com Semrush global rank: 2.35 M Semrush visits lastest month: 7.9 K
- Host name: 160.198.208.35.bc.googleusercontent.com
- IP address: 35.208.198.160
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "IceCure Medical Ltd."
About Us - IceCure
Apr 9, 2023 Prior to joining IceCure, Eyal served as CEO of medical device and export companies, including B-Cure Laser and Hanita Lenses. Eyal is a seasoned executive and has extensive experience in global business development, …See details»
Company Information :: IceCure Medical Ltd. (ICCM)
IceCure Medical Ltd. 7 Ha’Eshel Street PO Box 3163 Caesarea 3079504 Israel T: +972-4-623-0333 F: +972-4-623-0222 [email protected]. Email Alerts; Company Profile; …See details»
IceCure Medical Ltd. (ICCM)
Oct 20, 2024 IceCure Medical Ltd. 7 Ha’Eshel Street PO Box 3163 Caesarea 3079504 Israel T: +972-4-623-0333 F: +972-4-623-0222 [email protected]. Investor Relations. EVC Group Michael Polyviou Todd Kehrli T: …See details»
IceCure Medical - Crunchbase Company Profile
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for women’s health and interventional oncology. Founded in 2006 to advance the treatment of cancerous tumors, IceCure’s core …See details»
ProSense - IceCure
Apr 9, 2023 The ProSense system is a medical device that enables precise and targeted cryoablation treatments. Learn about our innovative technology. Skip to content. For Physicians; For Patients; ... IceCure Medical HQ: 7 Ha’Eshel St., …See details»
IceCure Medical - Funding, Financials, Valuation & Investors
IceCure is a medical device company focusing on minimally-invasive tumor therapy for women’s health and interventional oncology. Search Crunchbase. ... How much funding has this …See details»
Icecure Medical - Information and distributors around …
IceCure Medical is setting new standards in minimally invasive cryotherapy for women’s health and interventional oncology. Founded in 2006 to advance the treatment of cancerous tumors, our FDA-cleared and CE-marked ProSenseâ„¢ …See details»
IceCure Medical Reports 36% Sales Growth in the First Nine …
CAESAREA, Israel, Nov. 26, 2024 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation …See details»
IceCure Medical Ltd (ICCM) - Stock Analysis
3 days ago IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies …See details»
IceCure Medical: Advancing Cryotherapy For Cancer Treatment
Jan 25, 2022 IceCure Medical Ltd (NASDAQ:ICCM) is a commercial-stage Israeli medical device company with wholly-owned subsidiaries in the U.S., Hong Kong and China, advancing …See details»
IceCure Medical Reports 36% Sales Growth in the First Nine
Nov 26, 2024 --IceCure Medical Ltd., developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today reported …See details»
IceCure Medical Reports Final ICE3 Breast Cancer Cryoablation …
Apr 15, 2024 IceCure Medical Logo. The Company provided the following requested data to the FDA: ICE3 5-year follow up full data-set; sub-analysis of the ICE3 results compared with data …See details»
Medical Device Careers | IceCure
Apr 9, 2023 At the heart of our organization lies a relentless drive to do more and bring better healthcare through innovation. We thrive by envisioning, doing, and solving, constantly …See details»
IceCure Medical : Reports 36% Sales Growth in the First Nine …
Nov 26, 2024 Conference call to be held today at 10:00 am Eastern Time. CAESAREA, Israel, November 26, 2024 - IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or …See details»
IceCure Medical Reports 36% Sales Growth in the First
Nov 26, 2024 IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense® Cryoablation PR Newswire CAESAREA, Israel, Nov. …See details»
IceCure Medical Ltd. Announces Interim Results from the …
2 days ago Icecure Medical Ltd is an Israel-based company that is engaged in the healthcare sector. The Company operates as commercial stage medical device company focusing on the …See details»
IceCure Medical Ltd. (ICCM) Reports Q3 Loss, Misses Revenue …
Nov 26, 2024 IceCure Medical (ICCM) delivered earnings and revenue surprises of -14.29% and 5.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to …See details»
Patients - IceCure
At IceCure, we believe in empowering patients to have a choice in their tumor treatment. We understand that everyone is unique and there is no one size treatment that fits all. We believe …See details»
News - IceCure
Jul 20, 2020 Following IceCure’s accelerating global expansion, the company has received regulatory approval for the treatment of benign and cancerous tumors in many indications …See details»